✦ LIBER ✦

Five-year Efficacy and Toxicity Outcomes from a Phase I/II Trial of Increasingly Hypofractionated Radiation Therapy for Prostate Cancer

✍ Scribed by M.A. Ritter; J.D. Forman; P.A. Kupelian; D.G. Petereit; C.A. Lawton; R.J. Chappell; W.A. Tomé

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Five-year Results of Disease Control and

✍ A. Roux; M. Yassa; C. Lambert; B. Fortin; M. Audet-Lapointe; I. Drapeau; J. Baha 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Predictors of Acute Toxicity after Stere

✍ D.S. Hong; J.H. Heinzerling; Y. Lotan; L.C. Cho; J. Brindle; X. Xie; D. Pistenma 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 45 KB

A Phase II Trial of Varian Trilogy-based

✍ C.A. Mantz; E. Fernandez; I. Zucker; S. Harrison 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Stereotactic body radiation therapy as a

✍ C. Mantz; F. Abu Shahin; E. Grendys; J. Orr 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB

The efficacy of pharmacokinetic monitori

✍ C Norman Coleman; Lori Buswell; Lisa Noll; Nancy Riese; Mary-Ann Rose 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 660 KB

A Phase II Trial of Real-time Target Tra

✍ C.A. Mantz; E. Fernandez; I. Zucker; S. Harrison 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 38 KB